首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1788405

2025-2029年全球眼科藥物市場

Global Ophthalmology Therapeutics Market 2025-2029

出版日期: 2025年08月05日 | 出版商:

TechNavio | 英文 232 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計 2024 年至 2029 年期間眼科治療市場規模將成長至 253 億美元，預測期內複合年成長率為 7.4%。

本報告對眼科治療市場進行了全面的分析，包括市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

該報告提供了當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。市場受到眼科疾病盛行率上升、新型治療劑的核准和強大的藥物管道以及抗 VEGF 抑制劑的強勁成長的推動。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
同比	6.7%
複合年成長率	7.4%
增量金額	253億美元

這項研究客觀地結合了一手和二手訊息，包括來自行業主要參與者的意見。報告包含對主要企業的分析，以及按地區和供應商格局細分的綜合市場規模數據。報告包含歷史數據和預測數據。

研究指出，新型藥物輸送系統的開發是未來幾年推動眼科治療市場成長的主要因素之一，而增加策略性合作夥伴關係和基因治療產品研究將帶來巨大的市場需求。

市場區隔
比較：按產品
視網膜疾病藥物：2024 年至 2029 年市場規模及預測
青光眼治療藥物：2024 年至 2029 年市場規模及預測
乾眼症治療：2024-2029 年市場規模及預測
眼部感染疾病及發炎治療：2024 年至 2029 年市場規模及預測
其他：2024-2029 年市場規模及預測
按產品分類的市場機會

第10章依藥品類別細分市場

市場區隔
比較：按藥物類別
抗 VEGF 藥物：2024 年至 2029 年市場規模及預測
抗發炎藥物：2024 年至 2029 年市場規模及預測
青光眼治療藥物：2024 年至 2029 年市場規模及預測
感染疾病物：2024-2029 年市場規模及預測
其他：2024-2029 年市場規模及預測
各藥品類別的市場機會

第11章客戶情況

客戶概覽

第12章地區情勢

區域細分
區域比較
北美：市場規模及預測 2024-2029
歐洲：2024-2029 年市場規模及預測
亞洲：2024-2029 年市場規模及預測
世界其他地區：2024 年至 2029 年市場規模及預測
美國：市場規模與預測 2024-2029
加拿大：市場規模及預測（2024-2029）
德國：2024-2029年市場規模及預測
英國：市場規模及預測 2024-2029
日本：2024-2029 年市場規模及預測
法國：2024-2029年市場規模及預測
中國：市場規模及預測（2024-2029）
印度：市場規模及預測（2024-2029）
義大利：2024-2029 年市場規模及預測
韓國：市場規模及預測（2024-2029）
各地區市場機會

第13章促進因素、挑戰、機會與限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第14章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第15章競爭分析

公司簡介
企業排名指數
公司市場定位
AbbVie Inc.
Aldeyra Therapeutics Inc
Apellis Pharmaceuticals Inc.
Bausch Health Companies Inc.
Bayer AG
F. Hoffmann La Roche Ltd.
Novartis AG
Ocular Therapeutix Inc
Otsuka Pharmaceutical Co Ltd.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Santen Pharmaceutical Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Visufarma

第16章附錄

簡介目錄圖表

Product Code: IRTNTR40882

The ophthalmology therapeutics market is forecasted to grow by USD 25.3 bn during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of eye diseases, approval of novel therapeutics and strong drug pipeline, and strong uptake of anti-vegf inhibitors.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.7%
CAGR	7.4%
Incremental Value	$25.3 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's ophthalmology therapeutics market is segmented as below:

By Type

Prescription drugs
OTC drugs

By Product

Retinal disorder therapeutics
Glaucoma therapeutics
Dry eye disease therapeutics
Eye infections and inflammation therapeutics
Others

By Drug Class

Anti-VEGF
Anti-inflammatory
Anti-glaucoma
Anti-infectives
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of novel drug delivery systems as one of the prime reasons driving the ophthalmology therapeutics market growth during the next few years. Also, increase in strategic alliances and increasing research on gene therapy products will lead to sizable demand in the market.

The report on the ophthalmology therapeutics market covers the following areas:

Ophthalmology Therapeutics Market sizing
Ophthalmology Therapeutics Market forecast
Ophthalmology Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ophthalmology therapeutics market vendors that include AbbVie Inc., Alcon Inc., Aldeyra Therapeutics Inc, Alembic Pharmaceuticals Ltd., Apellis Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., MeiraGTx Holdings Plc., Novartis AG, Ocular Therapeutix Inc, Otsuka Pharmaceutical Co Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Visufarma. Also, the ophthalmology therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Ophthalmology Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Ophthalmology Therapeutics Market 2019 - 2023 ($ billion)
5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.3 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
5.4 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 The AI impact on Global Ophthalmology Therapeutics Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 Prescription drugs - Market size and forecast 2024-2029
- Chart on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
- Chart on Prescription drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%)
8.4 OTC drugs - Market size and forecast 2024-2029
- Chart on OTC drugs - Market size and forecast 2024-2029 ($ billion)
- Data Table on OTC drugs - Market size and forecast 2024-2029 ($ billion)
- Chart on OTC drugs - Year-over-year growth 2024-2029 (%)
- Data Table on OTC drugs - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)

9 Market Segmentation by Product

9.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
9.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
9.3 Retinal disorder therapeutics - Market size and forecast 2024-2029
- Chart on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
9.4 Glaucoma therapeutics - Market size and forecast 2024-2029
- Chart on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
9.5 Dry eye disease therapeutics - Market size and forecast 2024-2029
- Chart on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
9.6 Eye infections and inflammation therapeutics - Market size and forecast 2024-2029
- Chart on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)

10 Market Segmentation by Drug Class

10.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
10.3 Anti-VEGF - Market size and forecast 2024-2029
- Chart on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-VEGF - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-VEGF - Year-over-year growth 2024-2029 (%)
10.4 Anti-inflammatory - Market size and forecast 2024-2029
- Chart on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
10.5 Anti-glaucoma - Market size and forecast 2024-2029
- Chart on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
10.6 Anti-infectives - Market size and forecast 2024-2029
- Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
10.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ billion)
- Data Table on Market opportunity by Drug Class ($ billion)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Aldeyra Therapeutics Inc
- Aldeyra Therapeutics Inc - Overview
- Aldeyra Therapeutics Inc - Product / Service
- Aldeyra Therapeutics Inc - Key offerings
- SWOT
15.6 Apellis Pharmaceuticals Inc.
- Apellis Pharmaceuticals Inc. - Overview
- Apellis Pharmaceuticals Inc. - Product / Service
- Apellis Pharmaceuticals Inc. - Key offerings
- SWOT
15.7 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
15.8 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.10 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.11 Ocular Therapeutix Inc
- Ocular Therapeutix Inc - Overview
- Ocular Therapeutix Inc - Product / Service
- Ocular Therapeutix Inc - Key offerings
- SWOT
15.12 Otsuka Pharmaceutical Co Ltd.
- Otsuka Pharmaceutical Co Ltd. - Overview
- Otsuka Pharmaceutical Co Ltd. - Product / Service
- Otsuka Pharmaceutical Co Ltd. - Key offerings
- SWOT
15.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.14 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
15.15 Santen Pharmaceutical Co. Ltd.
- Santen Pharmaceutical Co. Ltd. - Overview
- Santen Pharmaceutical Co. Ltd. - Product / Service
- Santen Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.16 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.17 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
15.18 Visufarma
- Visufarma - Overview
- Visufarma - Product / Service
- Visufarma - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Ophthalmology Therapeutics Market 2019 - 2023 ($ billion)
Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits27: Historic Market Size - Product Segment 2019 - 2023 ($ billion)
Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Type - Market share 2024-2029 (%)
Exhibits39: Data Table on Type - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Type
Exhibits41: Data Table on Comparison by Type
Exhibits42: Chart on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits43: Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits44: Chart on Prescription drugs - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on OTC drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits47: Data Table on OTC drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits48: Chart on OTC drugs - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on OTC drugs - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Type ($ billion)
Exhibits51: Data Table on Market opportunity by Type ($ billion)
Exhibits52: Chart on Product - Market share 2024-2029 (%)
Exhibits53: Data Table on Product - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by Product
Exhibits55: Data Table on Comparison by Product
Exhibits56: Chart on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits57: Data Table on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits58: Chart on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits61: Data Table on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits62: Chart on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits65: Data Table on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits66: Chart on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits69: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits70: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits73: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits74: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits76: Market opportunity by Product ($ billion)
Exhibits77: Data Table on Market opportunity by Product ($ billion)
Exhibits78: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits79: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits80: Chart on Comparison by Drug Class
Exhibits81: Data Table on Comparison by Drug Class
Exhibits82: Chart on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
Exhibits83: Data Table on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
Exhibits84: Chart on Anti-VEGF - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Anti-VEGF - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
Exhibits87: Data Table on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
Exhibits88: Chart on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
Exhibits91: Data Table on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
Exhibits92: Chart on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
Exhibits94: Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
Exhibits95: Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
Exhibits96: Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
Exhibits98: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits99: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits100: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits101: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits102: Market opportunity by Drug Class ($ billion)
Exhibits103: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits107: Chart on Geographic comparison
Exhibits108: Data Table on Geographic comparison
Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits142: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits150: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits151: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits154: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits155: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits158: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits159: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits161: Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits162: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits163: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits164: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits165: Market opportunity By Geographical Landscape ($ billion)
Exhibits166: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits167: Impact of drivers and challenges in 2024 and 2029
Exhibits168: Overview on criticality of inputs and factors of differentiation
Exhibits169: Overview on factors of disruption
Exhibits170: Impact of key risks on business
Exhibits171: Companies covered
Exhibits172: Company ranking index
Exhibits173: Matrix on companies position and classification
Exhibits174: AbbVie Inc. - Overview
Exhibits175: AbbVie Inc. - Product / Service
Exhibits176: AbbVie Inc. - Key news
Exhibits177: AbbVie Inc. - Key offerings
Exhibits178: SWOT
Exhibits179: Aldeyra Therapeutics Inc - Overview
Exhibits180: Aldeyra Therapeutics Inc - Product / Service
Exhibits181: Aldeyra Therapeutics Inc - Key offerings
Exhibits182: SWOT
Exhibits183: Apellis Pharmaceuticals Inc. - Overview
Exhibits184: Apellis Pharmaceuticals Inc. - Product / Service
Exhibits185: Apellis Pharmaceuticals Inc. - Key offerings
Exhibits186: SWOT
Exhibits187: Bausch Health Companies Inc. - Overview
Exhibits188: Bausch Health Companies Inc. - Business segments
Exhibits189: Bausch Health Companies Inc. - Key news
Exhibits190: Bausch Health Companies Inc. - Key offerings
Exhibits191: Bausch Health Companies Inc. - Segment focus
Exhibits192: SWOT
Exhibits193: Bayer AG - Overview
Exhibits194: Bayer AG - Business segments
Exhibits195: Bayer AG - Key news
Exhibits196: Bayer AG - Key offerings
Exhibits197: Bayer AG - Segment focus
Exhibits198: SWOT
Exhibits199: F. Hoffmann La Roche Ltd. - Overview
Exhibits200: F. Hoffmann La Roche Ltd. - Business segments
Exhibits201: F. Hoffmann La Roche Ltd. - Key news
Exhibits202: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits203: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits204: SWOT
Exhibits205: Novartis AG - Overview
Exhibits206: Novartis AG - Business segments
Exhibits207: Novartis AG - Key news
Exhibits208: Novartis AG - Key offerings
Exhibits209: Novartis AG - Segment focus
Exhibits210: SWOT
Exhibits211: Ocular Therapeutix Inc - Overview
Exhibits212: Ocular Therapeutix Inc - Product / Service
Exhibits213: Ocular Therapeutix Inc - Key offerings
Exhibits214: SWOT
Exhibits215: Otsuka Pharmaceutical Co Ltd. - Overview
Exhibits216: Otsuka Pharmaceutical Co Ltd. - Product / Service
Exhibits217: Otsuka Pharmaceutical Co Ltd. - Key offerings
Exhibits218: SWOT
Exhibits219: Pfizer Inc. - Overview
Exhibits220: Pfizer Inc. - Product / Service
Exhibits221: Pfizer Inc. - Key news
Exhibits222: Pfizer Inc. - Key offerings
Exhibits223: SWOT
Exhibits224: Regeneron Pharmaceuticals Inc. - Overview
Exhibits225: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits226: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits227: SWOT
Exhibits228: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits229: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits230: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits231: SWOT
Exhibits232: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits233: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits234: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits235: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits236: SWOT
Exhibits237: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits238: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits239: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits240: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits241: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits242: SWOT
Exhibits243: Visufarma - Overview
Exhibits244: Visufarma - Product / Service
Exhibits245: Visufarma - Key offerings
Exhibits246: SWOT
Exhibits247: Inclusions checklist
Exhibits248: Exclusions checklist
Exhibits249: Currency conversion rates for US$
Exhibits250: Research methodology
Exhibits251: Information sources
Exhibits252: Data validation
Exhibits253: Validation techniques employed for market sizing
Exhibits254: Data synthesis
Exhibits255: 360 degree market analysis
Exhibits256: List of abbreviations